Literature DB >> 16117786

Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1.

Claudia Consoli1, Celia Moss, Stuart Green, Debra Balderson, David N Cooper, Meena Upadhyaya.   

Abstract

Segmental neurofibromatosis type 1 (SNF1), characterized by the regionally limited distribution of neurofibromatosis type 1 (NF1) features, has been attributed to mosaicism for an NF1 gene mutation. The occurrence of classical NF1 in the offspring of a parent with SNF1 suggests that cutaneous mosaicism may be accompanied by gonadal mosaicism. We studied a girl with generalized NF1, and her mother who has SNF1. A recurrent nonsense mutation in exon 31 (R1947X) of the NF1 gene was identified in the lymphocyte DNA of the affected child by denaturing high-performance liquid chromatography and PCR/direct sequencing. DNA sequence analysis failed, however, to identify the R1947X mutation in peripheral lymphocytes, and in keratinocytes and fibroblasts cultured from affected and unaffected skin in the mother. DNA fragments containing exon 31 were then cloned from each cell line and these clones were screened using allele-specific PCR. The R1947X mutation was identified in 29 of 146 clones derived from keratinocytes from the affected region and in 12 of 136 clones derived from fibroblasts from the affected region, but in no clones derived from clinically unaffected tissues. These findings confirm that gonosomal mosaicism can occur in SNF1, with consequent important implications for genetic counselling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16117786     DOI: 10.1111/j.0022-202X.2005.23834.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

Review 1.  Mosaicism in Cutaneous Disorders.

Authors:  Young H Lim; Zoe Moscato; Keith A Choate
Journal:  Annu Rev Genet       Date:  2017-11-27       Impact factor: 16.830

2.  Clinical and molecular characteristics of thirty NF1 variants in Chinese patients with neurofibromatosis type 1.

Authors:  Wen Wang; Weibing Qin; Hongsong Ge; Xiangsheng Kong; Chao Xie; Yunge Tang; Ming Li
Journal:  Mol Biol Rep       Date:  2019-06-14       Impact factor: 2.316

3.  Monozygotic twins discordant for neurofibromatosis 1.

Authors:  Lee Kaplan; Rosemary Foster; Yiping Shen; Dilys M Parry; Mary L McMaster; Melanie Collins O'Leary; James F Gusella
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

4.  NF1 exon 22 analysis of individuals with the clinical diagnosis of neurofibromatosis type 1.

Authors:  Talia M Muram-Zborovski; Cecily P Vaughn; David H Viskochil; Heather Hanson; Rong Mao; David A Stevenson
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

Review 5.  Neurofibromatosis type 1.

Authors:  Kevin P Boyd; Bruce R Korf; Amy Theos
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

6.  Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1.

Authors:  Ophélia Maertens; Sofie De Schepper; Jo Vandesompele; Hilde Brems; Ine Heyns; Sandra Janssens; Frank Speleman; Eric Legius; Ludwine Messiaen
Journal:  Am J Hum Genet       Date:  2007-06-20       Impact factor: 11.025

7.  Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.

Authors:  Sara H Osum; Alexander W Coutts; Dylan J Duerre; Barbara R Tschida; Mark N Kirstein; James Fisher; W Robert Bell; Oona Delpuech; Paul D Smith; Brigitte C Widemann; Christopher L Moertel; David A Largaespada; Adrienne L Watson
Journal:  Neurooncol Adv       Date:  2021-02-10

8.  A pathogenic mosaic TP53 mutation in two germ layers detected by next generation sequencing.

Authors:  Sam Behjati; Mariana Maschietto; Richard D Williams; Lucy Side; Mike Hubank; Rebecca West; Katie Pearson; Neil Sebire; Patrick Tarpey; Andrew Futreal; Tony Brooks; Michael R Stratton; John Anderson
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

9.  Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1.

Authors:  Sara H Isakson; Anthony E Rizzardi; Alexander W Coutts; Daniel F Carlson; Mark N Kirstein; James Fisher; Jeremie Vitte; Kyle B Williams; G Elizabeth Pluhar; Sonika Dahiya; Brigitte C Widemann; Eva Dombi; Tilat Rizvi; Nancy Ratner; Ludwine Messiaen; Anat O Stemmer-Rachamimov; Scott C Fahrenkrug; David H Gutmann; Marco Giovannini; Christopher L Moertel; David A Largaespada; Adrienne L Watson
Journal:  Commun Biol       Date:  2018-10-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.